ArticleSleep medicine2025
Sex differences in the relationship between self-selected sleep-wake timing and morning cardiovascular risk in midlife adults.
Article in Sleep medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Adverse cardiovascular (CV) events occur most frequently in the morning. People who wake up later in the morning appear to have an increased risk of these events, but the mechanisms causing this effect are unknown. Vascular endothelial function (VEF) is a prognostic marker for these adverse events. Thus, we hypothesized that later wake times are associated with impaired morning VEF. Moreover, since sex differences exist in sleep timing and cardiovascular physiology, we also explored sex differences in any such relationship between wake times and morning VEF. Twenty-four healthy volunteers self-selected a sleep schedule of 8 h in bed for at least one week and were provided with an equivalent 8 h sleep opportunity in the laboratory. We measured dim-light melatonin onset (DLMO) as a circadian phase marker from salivary samples and quantified sleep using polysomnography. After the 8-h sleep opportunity, we measured VEF via flow-mediated dilation. We tested correlations between self-selected sleep-wake timing and VEF. Results: In the group as a whole, there was no significant relationship between waketimes and VEF (r = -0.36, p = 0.16). However, in females, later wake time was significantly associated with attenuated VEF (r = -0.76, p = 0.03), and this was the complete opposite in males (r = 0.69, p = 0.04). Furthermore, in females, later DLMO (r = -0.77, p = 0.025) was also associated with attenuated VEF, but this relationship was not present in males. These initial data suggest that the time of awakening is associated with VEF during the vulnerable morning hours, but this relationship is the opposite between males and females.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.